Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
Nozaki
S
S
First Department of Surgery, Osaka University Medical School, Japan.
Ito
T
T
Kamiike
W
W
Uchikoshi
F
F
Yamamoto
S
S
Nakata
S
S
Shirakura
R
R
Miyata
M
M
Matsuda
H
H
Stepkowski
S M
SM
D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity / Q000187:drug effects; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation / Q000276:immunology*; D007114:Immunization; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D051381:Rats; D011915:Rats, Inbred BUF; D011917:Rats, Inbred Lew; D016038:Skin Transplantation / Q000276:immunology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000528:radiation effects; D016559:Tacrolimus / Q000627:therapeutic use; D014184:Transplantation, Homologous; D011798:Quinaldines
D001713:Biphenyl Compounds; D007166:Immunosuppressive Agents; D016559:Tacrolimus; C046943:brequinar; D011798:Quinaldines